ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 233 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $852,578 | -10.1% | 20,744 | +2.1% | 0.01% | -14.3% |
| Q1 2024 | $948,274 | -1.3% | 20,310 | +1.1% | 0.01% | 0.0% |
| Q4 2023 | $960,369 | +33.6% | 20,083 | -0.4% | 0.01% | +16.7% |
| Q3 2023 | $718,811 | -21.0% | 20,163 | +2.2% | 0.01% | -14.3% |
| Q2 2023 | $909,776 | +17.6% | 19,722 | +2.2% | 0.01% | 0.0% |
| Q1 2023 | $773,810 | -11.0% | 19,297 | +2.8% | 0.01% | -12.5% |
| Q4 2022 | $869,799 | +16.3% | 18,774 | +4.0% | 0.01% | 0.0% |
| Q3 2022 | $748,000 | -29.8% | 18,053 | +1.1% | 0.01% | -20.0% |
| Q2 2022 | $1,066,000 | -16.1% | 17,863 | +2.1% | 0.01% | 0.0% |
| Q1 2022 | $1,271,000 | -12.9% | 17,504 | +0.9% | 0.01% | -9.1% |
| Q4 2021 | $1,459,000 | -7.4% | 17,345 | -0.7% | 0.01% | -15.4% |
| Q3 2021 | $1,575,000 | -4.5% | 17,463 | +1.0% | 0.01% | 0.0% |
| Q2 2021 | $1,649,000 | -20.8% | 17,289 | -5.5% | 0.01% | -27.8% |
| Q1 2021 | $2,083,000 | -9.9% | 18,295 | +9.6% | 0.02% | -14.3% |
| Q4 2020 | $2,311,000 | +64.1% | 16,693 | -2.5% | 0.02% | +50.0% |
| Q3 2020 | $1,408,000 | +45.0% | 17,128 | +38.0% | 0.01% | 0.0% |
| Q2 2020 | $971,000 | +69.8% | 12,413 | -3.7% | 0.01% | +40.0% |
| Q1 2020 | $572,000 | – | 12,884 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
| Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
| Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
| AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
| EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
| FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
| HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
| Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |